unknown
Stage
2015
Founded
1
Investors
About
Betalin Therapeutics is an Israeli biotech company developing an implantable micro‑pancreas that uses transplanted insulin-producing cells and stem-cell technologies to sense blood glucose and release regulated insulin, aiming to reduce or eliminate patients' dependence on injected insulin for diabetes management.
Explore Betalin Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.